A Phase 3, Multicenter, Randomized, Double-blind, Single-dose Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis

Conditions: Glenohumeral Osteoarthritis Interventions: Drug: ZILRETTA; Drug: TCA-IR; Other: Placebo Sponsors: Pacira Pharmaceuticals, Inc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials